Evidence map›Paper›PMID 33738004›Full record

ArticleWorld journal of oncology2021

Clear Cell Carcinoma of the Cervix With OHVIRA Syndrome: A Rare Case Report.

Yasuhito Tanase, Hiroshi Yoshida, Tomoaki Naka, Shoichi Kitamura, Takashi Natsume, Mayumi Kobayashi Kato, Masaya Uno, Mitsuya Ishikawa, Ahmed Ali Mahmoud Ali, Tomoyasu Kato

Open access · diamondAbstract readCase Reports
In one paragraph

Article in World journal of oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Yasuhito TanaseDepartment of Gynecology, National Cancer Central Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Hiroshi YoshidaDepartment of Diagnostic Pathology, National Cancer Central Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Tomoaki NakaDepartment of Diagnostic Pathology, National Cancer Central Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Shoichi KitamuraDepartment of Gynecology, National Cancer Central Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Takashi NatsumeDepartment of Gynecology, National Cancer Central Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Mayumi Kobayashi KatoDepartment of Gynecology, National Cancer Central Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Masaya UnoDepartment of Gynecology, National Cancer Central Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Mitsuya IshikawaDepartment of Gynecology, National Cancer Central Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Ahmed Ali Mahmoud AliDepartment of Obstetrics and Gynaecology, Faculty of Medicine, Assiut University, 71515 Assiut, Egypt.
Tomoyasu KatoDepartment of Gynecology, National Cancer Central Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
National Cancer Center · USNational Cancer Centre Japan · JPNational Cancer Research Institute · GBAssiut University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obstructed hemivagina and ipsilateral renal agenesis (OHVIRA) syndrome is a rare Mullerian duct anomaly characterized by an obstructed hemivagina, ipsilateral renal agenesis, and uterine didelphys. There are only a few published case reports of OHVIRA syndrome, and cases of OHVIRA syndrome associated with cancer have rarely been reported. In fact, there is only one published report of a case with clear cell carcinoma (CCC) of the cervix. Here, we report a case of CCC of the cervix with OHVIRA syndrome that underwent abdominal radical hysterectomy; we also provide a short literature review of this topic. A 52-year-old woman presented with abnormal vaginal bleeding for 1 month 2 years after menopause. A pelvic examination and preoperative imaging showed uterine didelphys, an obstructed hemivagina with a mass measuring approximately 2 cm located in her left cervix, and an absence of her left kidney. A colposcopy biopsy reported CCC of the cervix. Clinical staging classified her with stage IB1 disease. Abdominal radical hysterectomy was performed. Her left ectopic ureter led to the left cervix and opened in the endometrium, resulting in a so-called ectopic ureter. Macroscopic examination of the excised specimens showed two cervixes, two corpora of the uterus, and a tumor measuring 1.0 × 2.0 cm on the left cervix. In addition to typical OHVIRA symptoms including uterine didelphys, obstructed hemivagina, and renal agenesis, several anatomical variants were present. The current case included those variants as well as an atrophic kidney with an ectopic ureter to the obstructed hemivagina. Based on the results of our case, clinicians should be aware of the risks of cancer and anatomical variants associated with OHVIRA syndrome.

Indexed as

Clear cell carcinoma of the cervixMullerian duct anomalyOHVIRA syndrome

Identifiers

PMID33738004
PMCPMC7935622
OpenAlexW3130253510

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.